We found that the combination of a defective ribosome biogenesis pathway and p53 activation resulted in unexpectedly strong anti-proliferative responses in human tumor cell lines in that they underwent senescence, differentiation, or apoptosis following depletion of RPS9. The gene discussed is TP53; the disease is neoplasm.